SCOTTSDALE, Arizona ― Second-generation antipsychotics (SGAs) differ with regard to efficacy and side effect profiles for the treatment of first-episode psychosis, according to the results of a new ...
Patients with schizophrenia on second-generation antipsychotics such as clozapine and olanzapine have an increased risk of diabetes and obesity. This randomized study of patients with schizophrenia ...
Semaglutide, a second-generation GLP-1 receptor agonist, was associated with significantly reduced body weight and other metabolic factors in adults with schizophrenia, prediabetes, and ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results